institutionid,scoredate,scoretype,aspectname,scorevalue,gvkey,ticker,companyname
4004092,2013-09-12,S&P Global ESG Score,S&P Global ESG Score,82,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Climate Change Governance,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Climate Strategy Impacts,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Climate-Related Management Incentives,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,EMS: Certification/ Audit/ Verification,68,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,EP - Biological Oxygen Demand,0,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,EP - Electricity Purchased,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Energy Use,90,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Environmental Reporting - Materiality,50,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Environmental Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Financial Opportunities Arising from Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Financial Risks of Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Hazardous Waste,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Low-Carbon Products,0,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Volatile Organic Compounds Emissions,21,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Water Use,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Analysis of Risks,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Audit Conflict of Interest,86,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Board Effectiveness,60,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Board Gender Diversity,88,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Board Type,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,CEO-to-Employee Pay Ratio,0,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Codes of Conduct: Coverage,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Corporate Governance Policy,88,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Customer Feedback Process,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Customer Satisfaction Measurement,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Direct-to-Consumer Marketing,0,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Direct-to-Consumer Marketing: Policies,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,ESG Integration in SCM Strategy,89,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Environmental Innovation,68,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Ethical Marketing - Complaints Tracking,70,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Open Innovation,85,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Opportunities,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Process Innovations,50,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Product Innovations (Healthcare),28,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,R&D Core or Basic Research,58,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,R&D Development Stages,78,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,R&D Ideation or Applied Research,90,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,R&D Launch,90,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,R&D Post-Launch,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,R&D Spending,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Responsibilities and Committees,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Responsibility Risk & Crisis Management,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Risk Response Strategy,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Sales Channels Variety & Innovation,85,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Sales Effectiveness Targets,66,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Sensitivity Analysis & Stress Testing,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Service Orientation,91,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Social Innovation,,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Supplier Risk Management Measures,81,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Supply Chain Risk Exposure,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Supply Chain Transparency & Reporting,55,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Transparency of Executive Compensation,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Access to Healthcare Programs (Products),100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Balance of Variable Compensation Based on Corporate and I,60,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Bioethics Policy,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Business and Human Rights,40,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Contribution to Increasing Healthcare Efficiency,10,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Corporate Citizenship Strategy,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Coverage of Employees through Predefined Performance Appr,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Employee Support Programs,94,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Employee Turnover Rate,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Fair Pricing,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Fatalities,40,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Health Management,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Healthy Lifestyle Incentive,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Human Capital Performance Indicators,20,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Human Resource Skill Mapping and Developing Process,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,78,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Measure Contribution to Health Outcome,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Measuring Benefits,50,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Network Orientation,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Payout Type of Total Performance-Related Compensation,0,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Percentage of Performance Related Compensation for each E,20,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Personal and Organizational Learning and Development,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Social Reporting - Materiality,32,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Social Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Stakeholder Engagement Governance,92,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Stakeholder Engagement Implementation,95,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Stakeholder Engagement Review,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Trend of Employee Wellbeing,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Volume,67,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Workforce Breakdown: Gender,74,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Dimension,Economic Governance Dimension,85,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Dimension,Environmental Dimension,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Dimension,Social Dimension,79,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Climate Strategy,71,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Environmental Policy & Management Systems,87,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Environmental Reporting,88,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Operational Eco-Efficiency,74,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Business Ethics,89,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Corporate Governance,85,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Customer Relationship Management,94,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Innovation Management,70,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Marketing Practices,81,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Risk & Crisis Management,97,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Supply Chain Management,90,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Access to Healthcare,90,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Addressing Cost Burden,45,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Bioethics,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Corporate Citizenship & Philanthropy,86,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Health Outcome Contribution,93,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Human Capital Development,68,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Labor Practice Indicators,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Occupational Health & Safety,82,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Social Reporting,83,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Stakeholder Engagement,97,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Talent Attraction & Retention,71,001078,ABT,Abbott Laboratories
4004092,2013-09-12,S&P Global ESG Score,S&P Global ESG Score,82,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Climate Change Governance,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Climate Strategy Impacts,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Climate-Related Management Incentives,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,EMS: Certification/ Audit/ Verification,68,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,EP - Biological Oxygen Demand,0,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,EP - Electricity Purchased,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Energy Use,90,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Environmental Reporting - Materiality,50,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Environmental Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Financial Opportunities Arising from Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Financial Risks of Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Hazardous Waste,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Low-Carbon Products,0,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Volatile Organic Compounds Emissions,21,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Water Use,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Analysis of Risks,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Audit Conflict of Interest,86,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Board Effectiveness,60,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Board Gender Diversity,88,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Board Type,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,CEO-to-Employee Pay Ratio,0,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Codes of Conduct: Coverage,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Corporate Governance Policy,88,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Customer Feedback Process,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Customer Satisfaction Measurement,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Direct-to-Consumer Marketing,0,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Direct-to-Consumer Marketing: Policies,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,ESG Integration in SCM Strategy,89,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Environmental Innovation,68,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Ethical Marketing - Complaints Tracking,70,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Open Innovation,85,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Opportunities,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Process Innovations,50,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Product Innovations (Healthcare),28,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,R&D Core or Basic Research,58,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,R&D Development Stages,78,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,R&D Ideation or Applied Research,90,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,R&D Launch,90,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,R&D Post-Launch,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,R&D Spending,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Responsibilities and Committees,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Responsibility Risk & Crisis Management,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Risk Response Strategy,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Sales Channels Variety & Innovation,85,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Sales Effectiveness Targets,66,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Sensitivity Analysis & Stress Testing,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Service Orientation,91,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Social Innovation,,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Supplier Risk Management Measures,81,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Supply Chain Risk Exposure,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Supply Chain Transparency & Reporting,55,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Transparency of Executive Compensation,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Access to Healthcare Programs (Products),100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Balance of Variable Compensation Based on Corporate and I,60,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Bioethics Policy,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Business and Human Rights,40,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Contribution to Increasing Healthcare Efficiency,10,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Corporate Citizenship Strategy,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Coverage of Employees through Predefined Performance Appr,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Employee Support Programs,94,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Employee Turnover Rate,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Fair Pricing,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Fatalities,40,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Health Management,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Healthy Lifestyle Incentive,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Human Capital Performance Indicators,20,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Human Resource Skill Mapping and Developing Process,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,78,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Measure Contribution to Health Outcome,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Measuring Benefits,50,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Network Orientation,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Payout Type of Total Performance-Related Compensation,0,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Percentage of Performance Related Compensation for each E,20,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Personal and Organizational Learning and Development,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Social Reporting - Materiality,32,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Social Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Stakeholder Engagement Governance,92,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Stakeholder Engagement Implementation,95,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Stakeholder Engagement Review,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Trend of Employee Wellbeing,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Volume,67,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Question,Workforce Breakdown: Gender,74,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Dimension,Economic Governance Dimension,85,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Dimension,Environmental Dimension,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Dimension,Social Dimension,79,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Climate Strategy,71,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Environmental Policy & Management Systems,87,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Environmental Reporting,88,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Operational Eco-Efficiency,74,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Business Ethics,89,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Corporate Governance,85,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Customer Relationship Management,94,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Innovation Management,70,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Marketing Practices,81,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Risk & Crisis Management,97,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Supply Chain Management,90,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Access to Healthcare,90,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Addressing Cost Burden,45,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Bioethics,100,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Corporate Citizenship & Philanthropy,86,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Health Outcome Contribution,93,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Human Capital Development,68,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Labor Practice Indicators,80,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Occupational Health & Safety,82,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Social Reporting,83,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Stakeholder Engagement,97,001078,ABT,Abbott Laboratories
4004092,2013-09-12,Criteria,Talent Attraction & Retention,71,001078,ABT,Abbott Laboratories
4004092,2014-09-11,S&P Global ESG Score,S&P Global ESG Score,83,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Climate Change Governance,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Climate Strategy Impacts,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Climate-Related Management Incentives,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,EMS: Certification/ Audit/ Verification,65,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,EP - Biological Oxygen Demand,50,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,EP - Electricity Purchased,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Energy Use,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Environmental Reporting - Materiality,58,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Environmental Reporting - Quantitative Data,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Financial Opportunities Arising from Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Financial Risks of Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Hazardous Waste,34,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Low-Carbon Products,0,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Volatile Organic Compounds Emissions,10,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Waste Disposal,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Water Use,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Analysis of Risks,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Audit Conflict of Interest,99,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Board Diversity Policy,67,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Board Gender Diversity,88,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Board Type,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,CEO-to-Employee Pay Ratio,0,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Codes of Conduct: Coverage,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Compliance to Regulatory Standards,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Corporate Governance Policy,88,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Customer Feedback Process,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Customer Satisfaction Measurement,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Direct-to-Consumer Marketing,68,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Direct-to-Consumer Marketing: Policies,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,ESG Integration in SCM Strategy,89,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Environmental Innovation,68,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Ethical Marketing - Complaints Tracking,70,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Expenses Associated with Product Recalls,0,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Initiatives Aimed at Ensuring Product Quality and Safety,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Open Innovation,98,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Opportunities,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Product Innovations (Healthcare),85,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Product Recalls (Health Care),50,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,R&D Core or Basic Research,90,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,R&D Development Stages,78,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,R&D Ideation or Applied Research,58,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,R&D Launch,90,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,R&D Post-Launch,90,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,R&D Spending,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Responsibilities and Committees,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Responsibility Risk & Crisis Management,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Risk Response Strategy,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Sales Channels Variety & Innovation,78,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Sensitivity Analysis & Stress Testing,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Service Orientation,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Social Innovation,,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Supplier Risk Management Measures,86,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Supply Chain Risk Exposure,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Supply Chain Transparency & Reporting,40,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Tax Reporting,50,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Tax Strategy and Governance,0,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Taxation Governance & Risks,25,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Transparency of Executive Compensation,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Access to Healthcare Programs (Products),100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Balance of Variable Compensation Based on Corporate and I,66,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Bioethics Policy,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Business and Human Rights,28,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,CEO Compensation - Success Metrics,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Corporate Citizenship Strategy,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Coverage of Employees through Predefined Performance Appr,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Employee Development Programs,30,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Employee Support Programs,94,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Employee Turnover Rate,88,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Fatalities,45,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Freedom of Association,50,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Gender Pay Indicators,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Health Management,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Healthy Lifestyle Incentive,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Human Capital Performance Indicators,20,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Human Capital Return on Investment,30,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Labor KPIs - Layoffs,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,79,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Measuring Benefits,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Network Orientation,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Percentage of Performance Related Compensation for each E,40,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Public Commitment to Human Rights,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Return on Employee Development Investment,0,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Social Reporting - Assurance,0,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Social Reporting - Materiality,34,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Social Reporting - Quantitative Data,59,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Stakeholder Engagement Governance,96,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Stakeholder Engagement Implementation,95,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Stakeholder Engagement Review,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Trend of Employee Wellbeing,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Volume,67,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Workforce Breakdown: Gender,70,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Dimension,Economic Governance Dimension,87,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Dimension,Environmental Dimension,76,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Dimension,Social Dimension,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Climate Strategy,68,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Environmental Policy & Management Systems,86,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Environmental Reporting,84,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Operational Eco-Efficiency,65,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Business Ethics,89,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Corporate Governance,87,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Customer Relationship Management,97,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Innovation Management,86,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Marketing Practices,89,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Product Quality & Recall Management,62,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Risk & Crisis Management,97,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Supply Chain Management,88,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Tax Strategy,44,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Access to Healthcare,90,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Bioethics,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Corporate Citizenship & Philanthropy,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Human Capital Development,36,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Labor Practice Indicators,83,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Occupational Health & Safety,84,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Social Reporting,48,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Stakeholder Engagement,98,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Talent Attraction & Retention,85,001078,ABT,Abbott Laboratories
4004092,2014-09-11,S&P Global ESG Score,S&P Global ESG Score,83,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Climate Change Governance,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Climate Strategy Impacts,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Climate-Related Management Incentives,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,EMS: Certification/ Audit/ Verification,65,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,EP - Biological Oxygen Demand,50,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,EP - Electricity Purchased,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Energy Use,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Environmental Reporting - Materiality,58,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Environmental Reporting - Quantitative Data,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Financial Opportunities Arising from Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Financial Risks of Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Hazardous Waste,34,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Low-Carbon Products,0,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Volatile Organic Compounds Emissions,10,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Waste Disposal,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Water Use,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Analysis of Risks,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Audit Conflict of Interest,99,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Board Diversity Policy,67,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Board Gender Diversity,88,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Board Type,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,CEO-to-Employee Pay Ratio,0,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Codes of Conduct: Coverage,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Compliance to Regulatory Standards,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Corporate Governance Policy,88,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Customer Feedback Process,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Customer Satisfaction Measurement,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Direct-to-Consumer Marketing,68,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Direct-to-Consumer Marketing: Policies,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,ESG Integration in SCM Strategy,89,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Environmental Innovation,68,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Ethical Marketing - Complaints Tracking,70,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Expenses Associated with Product Recalls,0,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Initiatives Aimed at Ensuring Product Quality and Safety,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Open Innovation,98,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Opportunities,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Product Innovations (Healthcare),85,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Product Recalls (Health Care),50,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,R&D Core or Basic Research,90,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,R&D Development Stages,78,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,R&D Ideation or Applied Research,58,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,R&D Launch,90,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,R&D Post-Launch,90,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,R&D Spending,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Responsibilities and Committees,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Responsibility Risk & Crisis Management,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Risk Response Strategy,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Sales Channels Variety & Innovation,78,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Sensitivity Analysis & Stress Testing,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Service Orientation,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Social Innovation,,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Supplier Risk Management Measures,86,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Supply Chain Risk Exposure,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Supply Chain Transparency & Reporting,40,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Tax Reporting,50,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Tax Strategy and Governance,0,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Taxation Governance & Risks,25,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Transparency of Executive Compensation,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Access to Healthcare Programs (Products),100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Balance of Variable Compensation Based on Corporate and I,66,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Bioethics Policy,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Business and Human Rights,28,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,CEO Compensation - Success Metrics,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Corporate Citizenship Strategy,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Coverage of Employees through Predefined Performance Appr,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Employee Development Programs,30,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Employee Support Programs,94,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Employee Turnover Rate,88,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Fatalities,45,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Freedom of Association,50,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Gender Pay Indicators,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Health Management,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Healthy Lifestyle Incentive,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Human Capital Performance Indicators,20,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Human Capital Return on Investment,30,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Labor KPIs - Layoffs,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,79,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Measuring Benefits,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Network Orientation,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Percentage of Performance Related Compensation for each E,40,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Public Commitment to Human Rights,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Return on Employee Development Investment,0,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Social Reporting - Assurance,0,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Social Reporting - Materiality,34,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Social Reporting - Quantitative Data,59,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Stakeholder Engagement Governance,96,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Stakeholder Engagement Implementation,95,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Stakeholder Engagement Review,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Trend of Employee Wellbeing,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Volume,67,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Question,Workforce Breakdown: Gender,70,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Dimension,Economic Governance Dimension,87,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Dimension,Environmental Dimension,76,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Dimension,Social Dimension,80,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Climate Strategy,68,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Environmental Policy & Management Systems,86,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Environmental Reporting,84,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Operational Eco-Efficiency,65,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Business Ethics,89,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Corporate Governance,87,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Customer Relationship Management,97,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Innovation Management,86,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Marketing Practices,89,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Product Quality & Recall Management,62,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Risk & Crisis Management,97,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Supply Chain Management,88,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Tax Strategy,44,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Access to Healthcare,90,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Bioethics,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Corporate Citizenship & Philanthropy,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Human Capital Development,36,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Labor Practice Indicators,83,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Occupational Health & Safety,84,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Social Reporting,48,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Stakeholder Engagement,98,001078,ABT,Abbott Laboratories
4004092,2014-09-11,Criteria,Talent Attraction & Retention,85,001078,ABT,Abbott Laboratories
4004092,2015-09-10,S&P Global ESG Score,S&P Global ESG Score,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Climate Change Governance,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Climate Strategy Impacts,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Climate-Related Management Incentives,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Direct Greenhouse Gas Emissions (Scope 1),94,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,EMS: Certification/ Audit/ Verification,66,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,EP - Biological Oxygen Demand,80,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,EP - Electricity Purchased,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Energy Use,98,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Environmental Reporting - Materiality,58,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Environmental Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Financial Opportunities Arising from Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Financial Risks of Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Hazardous Waste,56,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Low-Carbon Products,,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Volatile Organic Compounds Emissions,70,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Water Use,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Board Diversity Policy,60,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Board Gender Diversity,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Board Type,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,CEO Compensation - Success Metrics,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,CEO-to-Employee Pay Ratio,0,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Codes of Conduct: Coverage,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Compliance to Regulatory Standards,80,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Customer Satisfaction Measurement,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Customer Satisfaction Performance,,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Direct-to-Consumer Marketing,63,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Direct-to-Consumer Marketing: Policies,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Emerging Risks,45,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Environmental Innovation,68,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Ethical Marketing - Complaints Tracking,70,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Expenses Associated with Product Recalls,52,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Initiatives Aimed at Ensuring Product Quality and Safety,80,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Management Ownership Requirements,83,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Open Innovation,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Opportunities,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Product Innovations (Healthcare),85,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Product Recalls (Health Care),0,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,R&D Core or Basic Research,74,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,R&D Development Stages,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,R&D Ideation or Applied Research,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,R&D Launch,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,R&D Post-Launch,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Reporting on breaches,0,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Responsibilities and Committees,91,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Risk Governance,80,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Risks Correlation,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Sales Channels Variety & Innovation,83,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Sensitivity Analysis & Stress Testing (including Water an,60,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Service Orientation,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Social Innovation,84,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Supplier Risk Management Measures,86,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Supply Chain Risk Exposure,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Supply Chain Transparency & Reporting,54,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Tax Reporting,50,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Tax Strategy and Governance,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Taxation Governance & Risks,25,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Transparency of Executive Compensation,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Access to Healthcare Programs (Products),88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Bioethics Policy,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Business and Human Rights,28,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Corporate Citizenship Strategy,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Employee Development Programs,85,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Employee Support Programs,97,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Employee Turnover Rate,76,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Fatalities,45,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Freedom of Association,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Gender Pay Indicators,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Health Management,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Healthy Lifestyle Incentive,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Human Capital Performance Indicators,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Human Capital Return on Investment,80,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Labor KPIs - Layoffs,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Measuring Benefits,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Network Orientation,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Public Commitment to Human Rights,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Return on Employee Development Investment,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Social Reporting - Materiality,34,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Social Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Stakeholder Engagement Governance,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Stakeholder Engagement Implementation,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Stakeholder Engagement Review,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Trend of Employee Wellbeing,71,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Volume,67,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Workforce Breakdown: Gender,70,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Dimension,Economic Governance Dimension,86,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Dimension,Environmental Dimension,85,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Dimension,Social Dimension,91,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Climate Strategy,75,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Environmental Policy & Management Systems,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Environmental Reporting,89,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Operational Eco-Efficiency,86,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Business Ethics,85,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Corporate Governance,82,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Customer Relationship Management,96,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Innovation Management,87,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Marketing Practices,89,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Product Quality & Recall Management,62,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Risk & Crisis Management,87,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Supply Chain Management,91,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Tax Strategy,74,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Access to Healthcare,84,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Bioethics,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Corporate Citizenship & Philanthropy,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Human Capital Development,92,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Labor Practice Indicators,86,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Occupational Health & Safety,85,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Social Reporting,83,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Stakeholder Engagement,96,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Talent Attraction & Retention,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,S&P Global ESG Score,S&P Global ESG Score,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Climate Change Governance,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Climate Strategy Impacts,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Climate-Related Management Incentives,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Direct Greenhouse Gas Emissions (Scope 1),94,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,EMS: Certification/ Audit/ Verification,66,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,EP - Biological Oxygen Demand,80,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,EP - Electricity Purchased,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Energy Use,98,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Environmental Reporting - Materiality,58,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Environmental Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Financial Opportunities Arising from Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Financial Risks of Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Hazardous Waste,56,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Low-Carbon Products,,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Volatile Organic Compounds Emissions,70,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Water Use,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Board Diversity Policy,60,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Board Gender Diversity,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Board Type,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,CEO Compensation - Success Metrics,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,CEO-to-Employee Pay Ratio,0,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Codes of Conduct: Coverage,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Compliance to Regulatory Standards,80,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Customer Satisfaction Measurement,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Customer Satisfaction Performance,,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Direct-to-Consumer Marketing,63,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Direct-to-Consumer Marketing: Policies,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Emerging Risks,45,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Environmental Innovation,68,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Ethical Marketing - Complaints Tracking,70,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Expenses Associated with Product Recalls,0,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Initiatives Aimed at Ensuring Product Quality and Safety,80,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Management Ownership Requirements,83,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Open Innovation,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Opportunities,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Product Innovations (Healthcare),85,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Product Recalls (Health Care),0,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,R&D Core or Basic Research,74,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,R&D Development Stages,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,R&D Ideation or Applied Research,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,R&D Launch,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,R&D Post-Launch,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Reporting on breaches,0,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Responsibilities and Committees,91,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Risk Governance,80,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Risks Correlation,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Sales Channels Variety & Innovation,83,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Sensitivity Analysis & Stress Testing (including Water an,60,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Service Orientation,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Social Innovation,84,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Supplier Risk Management Measures,86,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Supply Chain Risk Exposure,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Supply Chain Transparency & Reporting,54,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Tax Reporting,50,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Tax Strategy and Governance,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Taxation Governance & Risks,25,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Transparency of Executive Compensation,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Access to Healthcare Programs (Products),88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Bioethics Policy,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Business and Human Rights,28,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Corporate Citizenship Strategy,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Employee Development Programs,85,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Employee Support Programs,97,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Employee Turnover Rate,76,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Fatalities,45,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Freedom of Association,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Gender Pay Indicators,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Health Management,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Healthy Lifestyle Incentive,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Human Capital Performance Indicators,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Human Capital Return on Investment,80,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Labor KPIs - Layoffs,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,90,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Measuring Benefits,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Network Orientation,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Public Commitment to Human Rights,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Return on Employee Development Investment,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Social Reporting - Materiality,34,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Social Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Stakeholder Engagement Governance,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Stakeholder Engagement Implementation,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Stakeholder Engagement Review,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Trend of Employee Wellbeing,71,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Volume,67,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Question,Workforce Breakdown: Gender,70,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Dimension,Economic Governance Dimension,86,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Dimension,Environmental Dimension,85,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Dimension,Social Dimension,91,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Climate Strategy,75,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Environmental Policy & Management Systems,88,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Environmental Reporting,89,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Operational Eco-Efficiency,86,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Business Ethics,85,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Corporate Governance,82,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Customer Relationship Management,96,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Innovation Management,87,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Marketing Practices,89,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Product Quality & Recall Management,52,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Risk & Crisis Management,87,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Supply Chain Management,91,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Tax Strategy,74,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Access to Healthcare,84,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Bioethics,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Corporate Citizenship & Philanthropy,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Human Capital Development,92,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Labor Practice Indicators,86,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Occupational Health & Safety,85,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Social Reporting,83,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Stakeholder Engagement,96,001078,ABT,Abbott Laboratories
4004092,2015-09-10,Criteria,Talent Attraction & Retention,88,001078,ABT,Abbott Laboratories
4004092,2016-09-08,S&P Global ESG Score,S&P Global ESG Score,85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Climate Change Governance,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Climate Strategy Impacts,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Climate-Related Management Incentives,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Coverage of Environmental Management Policy,88,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Direct Greenhouse Gas Emissions (Scope 1),94,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,EMS: Certification/ Audit/ Verification,64,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,EP - Biological Oxygen Demand,80,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,EP - Electricity Purchased,89,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Energy Use,97,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Environmental Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Financial Opportunities Arising from Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Financial Risks of Climate Change,70,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Hazardous Waste,70,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Volatile Organic Compounds Emissions,68,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Water Use,84,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Board Diversity Policy,70,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Board Gender Diversity,88,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Board Type,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,CEO Compensation - Success Metrics,81,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Codes of Conduct: Coverage,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Compliance to Regulatory Standards,96,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Customer Satisfaction Measurement,92,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Customer Satisfaction Performance,,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Direct-to-Consumer Marketing,55,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Emerging Risks,0,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Environmental Innovation,68,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Ethical Marketing - Complaints Tracking,75,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Expenses Associated with Product Recalls,0,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Management Ownership Requirements,83,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Material Issues for Enterprise Value Creation,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Materiality Analysis,63,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Open Innovation,97,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Opportunities,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Product Innovations (Healthcare),85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Product Recalls (Health Care),87,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,R&D Core or Basic Research,74,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,R&D Development Stages,82,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,R&D Ideation or Applied Research,90,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,R&D Launch,90,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,R&D Post-Launch,90,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Reporting on breaches,0,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Responsibilities and Committees,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Risk Governance,80,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Risks Correlation,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Sales Channels Variety & Innovation,83,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Sensitivity Analysis & Stress Testing (including Water an,60,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Service Orientation,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Social Innovation,84,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Supplier Risk Management Measures,89,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Supply Chain Risk Exposure,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Supply Chain Transparency & Reporting,54,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Tax Reporting,50,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Tax Strategy and Governance,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Taxation Governance & Risks,36,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Transparency of Executive Compensation,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Access to Healthcare Programs (Products),49,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Corporate Citizenship Strategy,95,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Employee Support Programs,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Employee Turnover Rate,63,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Fatalities,45,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Freedom of Association,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Gender Pay Indicators,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Health Management,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Healthy Lifestyle Incentive,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Human Capital Performance Indicators,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Human Rights Assessment,0,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Human Rights Commitment,67,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Human Rights Due Diligence Process,60,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Human Rights Mitigation & Remediation,40,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Labor KPIs - Layoffs,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,99,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,95,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Network Orientation,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Return on Employee Development Investment,0,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Social Reporting - Quantitative Data,93,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Trend of Employee Wellbeing,46,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Type of Philanthropic Activities,50,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Volume,67,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Workforce Breakdown: Gender,70,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Dimension,Economic Governance Dimension,86,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Dimension,Environmental Dimension,89,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Dimension,Social Dimension,83,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Climate Strategy,82,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Environmental Policy & Management Systems,84,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Operational Eco-Efficiency,86,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Business Ethics,85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Corporate Governance,85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Customer Relationship Management,94,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Innovation Management,85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Marketing Practices,88,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Materiality,89,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Product Quality & Recall Management,77,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Risk & Crisis Management,85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Supply Chain Management,91,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Tax Strategy,77,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Access to Healthcare,65,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Corporate Citizenship & Philanthropy,88,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Human Capital Development,80,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Labor Practice Indicators,67,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Occupational Health & Safety,85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Social Reporting,98,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Talent Attraction & Retention,81,001078,ABT,Abbott Laboratories
4004092,2016-09-08,S&P Global ESG Score,S&P Global ESG Score,85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Climate Change Governance,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Climate Strategy Impacts,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Climate-Related Management Incentives,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Coverage of Environmental Management Policy,88,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Direct Greenhouse Gas Emissions (Scope 1),94,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,EMS: Certification/ Audit/ Verification,64,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,EP - Biological Oxygen Demand,80,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,EP - Electricity Purchased,89,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Energy Use,97,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Environmental Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Financial Opportunities Arising from Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Financial Risks of Climate Change,70,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Hazardous Waste,70,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Volatile Organic Compounds Emissions,68,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Water Use,84,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Board Diversity Policy,70,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Board Gender Diversity,88,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Board Type,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,CEO Compensation - Success Metrics,81,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,CEO-to-Employee Pay Ratio,0,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Codes of Conduct: Coverage,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Compliance to Regulatory Standards,96,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Customer Satisfaction Measurement,92,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Customer Satisfaction Performance,,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Direct-to-Consumer Marketing,55,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Emerging Risks,0,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Environmental Innovation,68,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Ethical Marketing - Complaints Tracking,75,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Expenses Associated with Product Recalls,0,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Management Ownership Requirements,83,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Material Issues for Enterprise Value Creation,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Materiality Analysis,63,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Open Innovation,97,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Opportunities,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Product Innovations (Healthcare),85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Product Recalls (Health Care),87,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,R&D Core or Basic Research,74,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,R&D Development Stages,82,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,R&D Ideation or Applied Research,90,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,R&D Launch,90,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,R&D Post-Launch,90,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Reporting on breaches,0,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Responsibilities and Committees,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Risk Governance,80,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Risks Correlation,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Sales Channels Variety & Innovation,83,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Sensitivity Analysis & Stress Testing (including Water an,60,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Service Orientation,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Social Innovation,84,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Supplier Risk Management Measures,89,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Supply Chain Risk Exposure,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Supply Chain Transparency & Reporting,54,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Tax Reporting,50,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Tax Strategy and Governance,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Taxation Governance & Risks,36,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Transparency of Executive Compensation,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Access to Healthcare Programs (Products),49,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Corporate Citizenship Strategy,95,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Employee Support Programs,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Employee Turnover Rate,63,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Fatalities,45,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Freedom of Association,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Gender Pay Indicators,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Health Management,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Healthy Lifestyle Incentive,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Human Capital Performance Indicators,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Human Rights Assessment,0,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Human Rights Commitment,67,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Human Rights Due Diligence Process,60,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Human Rights Mitigation & Remediation,40,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Labor KPIs - Layoffs,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,99,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,95,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Network Orientation,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Return on Employee Development Investment,0,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Social Reporting - Quantitative Data,93,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Trend of Employee Wellbeing,46,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Type of Philanthropic Activities,50,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Volume,67,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Question,Workforce Breakdown: Gender,70,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Dimension,Economic Governance Dimension,86,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Dimension,Environmental Dimension,89,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Dimension,Social Dimension,83,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Climate Strategy,82,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Environmental Policy & Management Systems,84,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Operational Eco-Efficiency,86,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Business Ethics,85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Corporate Governance,83,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Customer Relationship Management,94,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Innovation Management,85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Marketing Practices,88,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Materiality,89,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Product Quality & Recall Management,77,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Risk & Crisis Management,85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Supply Chain Management,91,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Tax Strategy,77,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Access to Healthcare,65,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Corporate Citizenship & Philanthropy,88,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Human Capital Development,80,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Labor Practice Indicators,67,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Occupational Health & Safety,85,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Social Reporting,98,001078,ABT,Abbott Laboratories
4004092,2016-09-08,Criteria,Talent Attraction & Retention,81,001078,ABT,Abbott Laboratories
4004092,2017-09-07,S&P Global ESG Score,S&P Global ESG Score,88,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Climate Strategy - CDP Alignment,,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Climate-Related Management Incentives,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Direct Greenhouse Gas Emissions (Scope 1),65,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,EMS: Certification/ Audit/ Verification,76,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,EP - Biological Oxygen Demand,58,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Energy Consumption,56,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Environmental Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Financial Opportunities Arising from Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Financial Risks of Climate Change,70,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Hazardous Waste,88,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 2),84,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Volatile Organic Compounds Emissions,70,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Waste Disposal,88,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Water Consumption,52,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Anti-Competitive Practices,85,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Board Effectiveness,58,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Board Gender Diversity,78,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Board Industry Experience,27,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Board Type,82,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,CEO Compensation - Success Metrics,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,CEO-to-Employee Pay Ratio,0,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Codes of Conduct: Coverage,74,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Compliance to Regulatory Standards,97,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Contributions & Other Spending,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Corruption & Bribery Cases,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Customer Satisfaction Measurement,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Direct-to-Consumer Marketing,64,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,ESG Integration in SCM Strategy,60,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Emerging Risks,65,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Environmental Innovation,84,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Expenses Associated with Product Recalls,52,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Impact Valuation,0,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Largest Contributions & Expenditures,80,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Management Ownership Requirements,83,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Material Issues for Enterprise Value Creation,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Materiality Analysis,88,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Product Innovations (Healthcare),85,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Product Recalls (Health Care),86,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,R&D Core or Basic Research,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,R&D Development Stages,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,R&D Ideation or Applied Research,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,R&D Launch,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Responsibilities and Committees,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Risk Governance,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Risks Correlation,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Sales Channels Variety & Innovation,82,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Sensitivity Analysis & Stress Testing (including Water an,75,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Social Innovation,84,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Supplier Code of Conduct,80,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Supplier Risk Management Measures,55,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Supply Chain Risk Exposure,88,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Supply Chain Transparency & Reporting,58,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Tax Reporting,50,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Tax Strategy and Governance,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Taxation Governance & Risks,52,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Valuation Disclosure,0,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Access to Healthcare Programs (Products),88,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Corporate Citizenship Strategy,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Employee Support Programs,83,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Employee Turnover Rate,71,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Fatalities,75,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Freedom of Association,50,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Gender Pay Indicators,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Healthy Lifestyle Incentive,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Human Rights Assessment,49,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Human Rights Commitment,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Human Rights Due Diligence Process,60,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Human Rights Mitigation & Remediation,40,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,95,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Network Orientation,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Return on Employee Development Investment,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Social Reporting - Quantitative Data,93,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Trend of Employee Wellbeing,,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Volume,67,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Workforce Breakdown: Gender,70,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Dimension,Economic Governance Dimension,86,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Dimension,Environmental Dimension,85,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Dimension,Social Dimension,92,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Climate Strategy,76,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Environmental Policy & Management Systems,91,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Operational Eco-Efficiency,70,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Business Ethics,93,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Corporate Governance,78,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Customer Relationship Management,95,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Impact Measurement & Valuation,0,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Innovation Management,89,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Marketing Practices,93,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Materiality,96,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Policy Influence,92,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Product Quality & Recall Management,87,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Risk & Crisis Management,92,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Supply Chain Management,79,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Tax Strategy,81,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Access to Healthcare,84,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Corporate Citizenship & Philanthropy,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Human Capital Development,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Human Rights,70,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Labor Practice Indicators,83,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Occupational Health & Safety,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Social Reporting,98,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Talent Attraction & Retention,91,001078,ABT,Abbott Laboratories
4004092,2017-09-07,S&P Global ESG Score,S&P Global ESG Score,87,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Climate Strategy - CDP Alignment,,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Climate-Related Management Incentives,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Direct Greenhouse Gas Emissions (Scope 1),65,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,EMS: Certification/ Audit/ Verification,76,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,EP - Biological Oxygen Demand,58,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Energy Consumption,56,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Environmental Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Financial Opportunities Arising from Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Financial Risks of Climate Change,70,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Hazardous Waste,88,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 2),84,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 3),67,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Volatile Organic Compounds Emissions,70,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Waste Disposal,88,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Water Consumption,52,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Anti-Competitive Practices,85,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Board Effectiveness,58,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Board Gender Diversity,78,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Board Industry Experience,27,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Board Type,82,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,CEO Compensation - Success Metrics,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,CEO-to-Employee Pay Ratio,0,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Codes of Conduct: Coverage,74,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Compliance to Regulatory Standards,97,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Contributions & Other Spending,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Corruption & Bribery Cases,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Customer Satisfaction Measurement,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Direct-to-Consumer Marketing,64,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,ESG Integration in SCM Strategy,60,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Emerging Risks,65,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Environmental Innovation,84,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Expenses Associated with Product Recalls,0,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Impact Valuation,0,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Initiatives Aimed at Ensuring Product Quality and Safety,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Largest Contributions & Expenditures,80,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Management Ownership Requirements,83,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Material Issues for Enterprise Value Creation,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Materiality Analysis,88,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Product Innovations (Healthcare),85,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Product Recalls (Health Care),86,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,R&D Core or Basic Research,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,R&D Development Stages,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,R&D Ideation or Applied Research,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,R&D Launch,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Responsibilities and Committees,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Risk Governance,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Risks Correlation,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Sales Channels Variety & Innovation,82,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Sensitivity Analysis & Stress Testing (including Water an,75,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Social Innovation,84,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Supplier Code of Conduct,80,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Supplier Risk Management Measures,55,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Supply Chain Risk Exposure,88,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Supply Chain Transparency & Reporting,58,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Tax Reporting,50,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Tax Strategy and Governance,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Taxation Governance & Risks,52,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Valuation Disclosure,0,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Access to Healthcare Programs (Products),88,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Corporate Citizenship Strategy,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Employee Support Programs,83,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Employee Turnover Rate,71,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Fatalities,75,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Freedom of Association,50,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Gender Pay Indicators,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Healthy Lifestyle Incentive,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Human Rights Assessment,0,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Human Rights Commitment,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Human Rights Due Diligence Process,60,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Human Rights Mitigation & Remediation,40,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,95,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Network Orientation,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Occupational Illness Frequency Rate (OIFR) - Employees,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Return on Employee Development Investment,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Social Reporting - Quantitative Data,93,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Trend of Employee Wellbeing,,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Volume,67,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Question,Workforce Breakdown: Gender,70,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Dimension,Economic Governance Dimension,85,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Dimension,Environmental Dimension,85,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Dimension,Social Dimension,91,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Climate Strategy,76,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Environmental Policy & Management Systems,91,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Operational Eco-Efficiency,70,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Business Ethics,93,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Corporate Governance,78,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Customer Relationship Management,95,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Impact Measurement & Valuation,0,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Innovation Management,89,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Marketing Practices,93,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Materiality,96,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Policy Influence,92,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Product Quality & Recall Management,77,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Risk & Crisis Management,92,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Supply Chain Management,79,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Tax Strategy,81,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Access to Healthcare,84,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Corporate Citizenship & Philanthropy,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Human Capital Development,100,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Human Rights,60,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Labor Practice Indicators,83,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Occupational Health & Safety,90,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Social Reporting,98,001078,ABT,Abbott Laboratories
4004092,2017-09-07,Criteria,Talent Attraction & Retention,91,001078,ABT,Abbott Laboratories
4004092,2018-09-13,S&P Global ESG Score,S&P Global ESG Score,82,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Climate Strategy - CDP Alignment,,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Climate-Related Management Incentives,78,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),95,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,EMS: Certification/ Audit/ Verification,77,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,EP - Biological Oxygen Demand,28,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Emissions Reduction Targets,80,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Energy Consumption,80,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Environmental Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Financial Opportunities Arising from Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Financial Risks of Climate Change,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Hazardous Waste,80,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),95,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Volatile Organic Compounds Emissions,70,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Waste Disposal,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Water Consumption,95,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Anti-Competitive Practices,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Board Gender Diversity,95,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Board Industry Experience,17,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Board Type,79,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,CEO Compensation - Long-Term Performance Alignment,70,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Compliance to Regulatory Standards,40,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Contributions & Other Spending,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Corruption & Bribery,60,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Corruption & Bribery Cases,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Customer Satisfaction Measurement,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,ESG Integration in SCM Strategy,60,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Effective Tax Rate,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Emerging Risks,0,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Family Ownership,0,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Largest Contributions & Expenditures,76,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Management Ownership Requirements,60,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Material Issues for Enterprise Value Creation,75,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Materiality Analysis,88,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Product Innovations (Healthcare),58,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Product Recalls (Health Care),83,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,R&D Core or Basic Research,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,R&D Development Stages,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,R&D Ideation or Applied Research,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,R&D Launch,86,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Risk Governance,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Sales Channels Variety & Innovation,83,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Supplier Risk Management Measures,85,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Supply Chain Risk Exposure,88,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Supply Chain Transparency & Reporting,68,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Tax Reporting,50,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Tax Strategy and Governance,50,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Access to Healthcare Programs (Products),55,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Corporate Citizenship Strategy,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Employee Support Programs,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Employee Turnover Rate,70,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Fatalities,70,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Freedom of Association,50,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Gender Pay Indicators,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Human Rights Assessment,31,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Human Rights Commitment,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Human Rights Due Diligence Process,20,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Human Rights Mitigation & Remediation,0,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,56,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Return on Employee Development Investment,0,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Social Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Trend of Employee Wellbeing,,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Workforce Breakdown: Gender,40,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Dimension,Economic Governance Dimension,81,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Dimension,Environmental Dimension,87,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Dimension,Social Dimension,81,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Climate Strategy,78,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Environmental Policy & Management Systems,88,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Operational Eco-Efficiency,80,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Business Ethics,85,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Corporate Governance,76,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Customer Relationship Management,94,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Innovation Management,82,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Materiality,79,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Policy Influence,91,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Product Quality & Recall Management,62,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Risk & Crisis Management,85,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Supply Chain Management,82,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Tax Strategy,61,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Access to Healthcare,71,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Corporate Citizenship & Philanthropy,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Human Capital Development,75,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Human Rights,38,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Labor Practice Indicators,64,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Occupational Health & Safety,82,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Talent Attraction & Retention,88,001078,ABT,Abbott Laboratories
4004092,2018-09-13,S&P Global ESG Score,S&P Global ESG Score,82,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Climate Strategy - CDP Alignment,,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Climate-Related Management Incentives,78,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),95,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,EMS: Certification/ Audit/ Verification,77,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,EP - Biological Oxygen Demand,28,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Emissions Reduction Targets,80,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Energy Consumption,80,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Environmental Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Financial Opportunities Arising from Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Financial Risks of Climate Change,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Hazardous Waste,80,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),95,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Volatile Organic Compounds Emissions,70,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Waste Disposal,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Water Consumption,95,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Anti-Competitive Practices,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Board Gender Diversity,95,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Board Industry Experience,17,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Board Type,79,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,CEO Compensation - Long-Term Performance Alignment,70,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Compliance to Regulatory Standards,40,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Contributions & Other Spending,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Corruption & Bribery,60,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Corruption & Bribery Cases,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Customer Satisfaction Measurement,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,ESG Integration in SCM Strategy,60,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Effective Tax Rate,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Emerging Risks,0,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Family Ownership,0,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Largest Contributions & Expenditures,76,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Management Ownership Requirements,60,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Material Issues for Enterprise Value Creation,75,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Materiality Analysis,88,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Product Innovations (Healthcare),58,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Product Recalls (Health Care),83,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,R&D Core or Basic Research,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,R&D Development Stages,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,R&D Ideation or Applied Research,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,R&D Launch,86,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Risk Governance,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Sales Channels Variety & Innovation,83,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Supplier Risk Management Measures,85,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Supply Chain Risk Exposure,88,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Supply Chain Transparency & Reporting,68,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Tax Reporting,50,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Tax Strategy and Governance,50,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Access to Healthcare Programs (Products),55,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Corporate Citizenship Strategy,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Employee Support Programs,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Employee Turnover Rate,70,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Fatalities,70,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Freedom of Association,50,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Gender Pay Indicators,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Human Rights Assessment,0,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Human Rights Commitment,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Human Rights Due Diligence Process,20,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Human Rights Mitigation & Remediation,0,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,56,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,90,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Return on Employee Development Investment,0,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Social Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Trend of Employee Wellbeing,,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Question,Workforce Breakdown: Gender,40,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Dimension,Economic Governance Dimension,81,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Dimension,Environmental Dimension,87,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Dimension,Social Dimension,80,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Climate Strategy,78,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Environmental Policy & Management Systems,88,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Operational Eco-Efficiency,80,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Business Ethics,85,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Corporate Governance,76,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Customer Relationship Management,94,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Innovation Management,82,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Materiality,79,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Policy Influence,91,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Product Quality & Recall Management,62,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Risk & Crisis Management,85,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Supply Chain Management,82,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Tax Strategy,61,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Access to Healthcare,71,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Corporate Citizenship & Philanthropy,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Human Capital Development,75,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Human Rights,30,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Labor Practice Indicators,64,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Occupational Health & Safety,82,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2018-09-13,Criteria,Talent Attraction & Retention,88,001078,ABT,Abbott Laboratories
4004092,2019-09-13,S&P Global ESG Score,S&P Global ESG Score,85,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,EMS: Certification/ Audit/ Verification,76,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Emissions Reduction Targets,80,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Energy Consumption,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Environmental Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Hazardous Waste,80,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Water Consumption,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Anti-Competitive Practices,80,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Board Gender Diversity,95,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Board Industry Experience,28,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Board Type,90,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,CEO Compensation - Long-Term Performance Alignment,70,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Compliance to Regulatory Standards,58,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Corruption & Bribery,60,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Corruption & Bribery Cases,80,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Customer Satisfaction Measurement,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Effective Tax Rate,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Emerging Risks,0,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Largest Contributions & Expenditures,36,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Management Ownership Requirements,60,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Material Issues for Enterprise Value Creation,75,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Materiality Analysis,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Product Innovations (Healthcare),65,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Product Recalls (Health Care),83,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,R&D Core or Basic Research,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,R&D Development Stages,92,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,R&D Ideation or Applied Research,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,R&D Launch,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Risk Governance,90,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Supplier Risk Management Measures,85,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Supply Chain Risk Exposure,88,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Supply Chain Transparency & Reporting,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Tax Reporting,50,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Tax Strategy and Governance,50,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Access to Healthcare Programs (Products),56,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Corporate Citizenship Strategy,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Employee Support Programs,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Employee Turnover Rate,69,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Fatalities,70,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Freedom of Association,50,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Gender Pay Indicators,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Human Capital Return on Investment,60,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Human Rights Assessment,30,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Human Rights Commitment,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Human Rights Due Diligence Process,20,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Human Rights Mitigation & Remediation,0,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,77,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,76,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Return on Employee Development Investment,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Social Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Trend of Employee Wellbeing,30,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Workforce Breakdown: Gender,89,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Dimension,Economic Governance Dimension,84,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Dimension,Environmental Dimension,95,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Dimension,Social Dimension,83,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Climate Strategy,91,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Environmental Policy & Management Systems,87,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Operational Eco-Efficiency,97,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Business Ethics,79,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Corporate Governance,82,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Customer Relationship Management,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Innovation Management,89,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Materiality,83,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Policy Influence,65,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Product Quality & Recall Management,71,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Risk & Crisis Management,85,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Supply Chain Management,95,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Tax Strategy,61,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Access to Healthcare,71,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Corporate Citizenship & Philanthropy,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Human Capital Development,92,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Human Rights,38,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Labor Practice Indicators,82,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Occupational Health & Safety,82,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Talent Attraction & Retention,74,001078,ABT,Abbott Laboratories
4004092,2019-09-13,S&P Global ESG Score,S&P Global ESG Score,85,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,EMS: Certification/ Audit/ Verification,76,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Emissions Reduction Targets,80,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Energy Consumption,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Environmental Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Hazardous Waste,80,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Water Consumption,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Anti-Competitive Practices,80,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Board Gender Diversity,95,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Board Industry Experience,28,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Board Type,90,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,CEO Compensation - Long-Term Performance Alignment,70,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Compliance to Regulatory Standards,58,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Corruption & Bribery,60,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Corruption & Bribery Cases,80,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Customer Satisfaction Measurement,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Effective Tax Rate,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Emerging Risks,0,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Largest Contributions & Expenditures,36,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Management Ownership Requirements,60,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Material Issues for Enterprise Value Creation,75,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Materiality Analysis,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Product Innovations (Healthcare),65,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Product Recalls (Health Care),83,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,R&D Core or Basic Research,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,R&D Development Stages,92,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,R&D Ideation or Applied Research,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,R&D Launch,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Risk Governance,90,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Supplier Risk Management Measures,85,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Supply Chain Risk Exposure,88,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Supply Chain Transparency & Reporting,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Tax Reporting,50,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Tax Strategy and Governance,50,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Access to Healthcare Programs (Products),56,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Corporate Citizenship Strategy,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Employee Support Programs,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Employee Turnover Rate,69,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Fatalities,70,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Freedom of Association,50,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Gender Pay Indicators,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Human Capital Return on Investment,60,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Human Rights Assessment,30,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Human Rights Commitment,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Human Rights Due Diligence Process,20,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Human Rights Mitigation & Remediation,0,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,77,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,76,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Return on Employee Development Investment,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Social Reporting - Quantitative Data,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Trend of Employee Wellbeing,30,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Question,Workforce Breakdown: Gender,89,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Dimension,Economic Governance Dimension,84,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Dimension,Environmental Dimension,95,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Dimension,Social Dimension,83,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Climate Strategy,91,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Environmental Policy & Management Systems,87,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Operational Eco-Efficiency,97,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Business Ethics,79,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Corporate Governance,82,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Customer Relationship Management,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Innovation Management,89,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Materiality,83,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Policy Influence,65,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Product Quality & Recall Management,71,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Risk & Crisis Management,85,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Supply Chain Management,95,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Tax Strategy,61,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Access to Healthcare,71,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Corporate Citizenship & Philanthropy,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Human Capital Development,92,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Human Rights,38,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Labor Practice Indicators,82,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Occupational Health & Safety,82,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2019-09-13,Criteria,Talent Attraction & Retention,74,001078,ABT,Abbott Laboratories
4004092,2020-11-13,S&P Global ESG Score,S&P Global ESG Score,86,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Coverage of Environmental Management Policy,80,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,EMS: Certification/ Audit/ Verification,75,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Emissions Reduction Targets,80,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Energy Consumption,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Hazardous Waste,90,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Water Consumption,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Anti-Competitive Practices,80,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Board Gender Diversity,86,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Board Industry Experience,28,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Board Type,76,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,CEO Compensation - Long-Term Performance Alignment,58,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Codes of Conduct: Systems/ Procedures,78,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Compliance to Regulatory Standards,68,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Corruption & Bribery Cases,80,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Customer Satisfaction Measurement,76,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,ESG Integration in SCM Strategy,60,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Effective Tax Rate,68,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Emerging Risks,80,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,IT Security/ Cybersecurity Breaches,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,IT Security/ Cybersecurity Governance,50,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,IT Security/ Cybersecurity Measures,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,IT Security/ Cybersecurity Process & Infrastructure,74,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Largest Contributions & Expenditures,60,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Management Ownership Requirements,68,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Material Issues for Enterprise Value Creation,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Materiality Analysis,75,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Non-Executive Chairperson/ Lead Director,70,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Product Innovations (Healthcare),58,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Product Recalls (Health Care),80,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,R&D breakout by Innovation Phase,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Risk Governance,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Supplier Risk Management Measures,85,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Supply Chain Risk Exposure,88,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Supply Chain Transparency & Reporting,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Tax Reporting,0,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Tax Strategy and Governance,50,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Access to Healthcare Programs (Products),71,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Corporate Citizenship Strategy,95,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Employee Support Programs,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Employee Turnover Rate,67,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Fatalities,70,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Freedom of Association,50,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Gender Pay Indicators,80,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Human Capital Return on Investment,80,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Human Rights Assessment,31,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Human Rights Commitment,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Human Rights Due Diligence Process,80,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Human Rights Mitigation & Remediation,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,91,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,51,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,76,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Return on Employee Development Investment,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Trend of Employee Wellbeing,45,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Question,Workforce Breakdown: Gender,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Dimension,Economic Governance Dimension,84,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Dimension,Environmental Dimension,93,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Dimension,Social Dimension,87,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Climate Strategy,91,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Environmental Policy & Management Systems,77,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Operational Eco-Efficiency,98,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Business Ethics,84,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Corporate Governance,79,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Customer Relationship Management,92,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Information Security/ Cybersecurity & System Availability,77,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Innovation Management,84,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Materiality,93,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Policy Influence,74,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Product Quality & Recall Management,74,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Risk & Crisis Management,98,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Supply Chain Management,89,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Tax Strategy,39,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Access to Healthcare,81,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Corporate Citizenship & Philanthropy,97,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Human Capital Development,96,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Human Rights,78,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Labor Practice Indicators,79,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Occupational Health & Safety,78,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2020-11-13,Criteria,Talent Attraction & Retention,77,001078,ABT,Abbott Laboratories
4004092,2021-04-15,S&P Global ESG Score,S&P Global ESG Score,86,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,EMS: Certification/ Audit/ Verification,75,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Emissions Reduction Targets,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Energy Consumption,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Hazardous Waste,90,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Water Consumption,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Anti-Competitive Practices,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Board Gender Diversity,86,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Board Industry Experience,28,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Board Type,76,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,CEO Compensation - Long-Term Performance Alignment,58,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Codes of Conduct: Systems/ Procedures,78,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Compliance to Regulatory Standards,68,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Corruption & Bribery Cases,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Customer Satisfaction Measurement,76,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,ESG Integration in SCM Strategy,60,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Effective Tax Rate,68,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Emerging Risks,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,IT Security/ Cybersecurity Breaches,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,IT Security/ Cybersecurity Governance,50,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,IT Security/ Cybersecurity Measures,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,IT Security/ Cybersecurity Process & Infrastructure,74,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Largest Contributions & Expenditures,60,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Management Ownership Requirements,68,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Material Issues for Enterprise Value Creation,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Materiality Analysis,75,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Non-Executive Chairperson/ Lead Director,70,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Product Innovations (Healthcare),58,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Product Recalls (Health Care),80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,R&D breakout by Innovation Phase,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Risk Governance,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Supplier Risk Management Measures,85,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Supply Chain Risk Exposure,88,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Supply Chain Transparency & Reporting,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Tax Reporting,0,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Tax Strategy and Governance,50,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Access to Healthcare Programs (Products),71,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Corporate Citizenship Strategy,95,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Employee Support Programs,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Employee Turnover Rate,67,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Fatalities,70,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Freedom of Association,50,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Gender Pay Indicators,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Human Capital Return on Investment,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Human Rights Assessment,31,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Human Rights Commitment,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Human Rights Due Diligence Process,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Human Rights Mitigation & Remediation,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,91,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,51,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Occupational Illness Frequency Rate (OIFR) - Employees,76,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Return on Employee Development Investment,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Trend of Employee Wellbeing,45,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Workforce Breakdown: Gender,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Dimension,Economic Governance Dimension,84,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Dimension,Environmental Dimension,95,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Dimension,Social Dimension,87,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Climate Strategy,91,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Environmental Policy & Management Systems,86,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Operational Eco-Efficiency,98,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Business Ethics,84,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Corporate Governance,79,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Customer Relationship Management,92,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Information Security/ Cybersecurity & System Availability,77,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Innovation Management,84,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Materiality,93,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Policy Influence,74,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Product Quality & Recall Management,74,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Risk & Crisis Management,98,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Supply Chain Management,89,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Tax Strategy,39,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Access to Healthcare,81,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Corporate Citizenship & Philanthropy,97,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Human Capital Development,96,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Human Rights,78,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Labor Practice Indicators,79,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Occupational Health & Safety,78,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Talent Attraction & Retention,77,001078,ABT,Abbott Laboratories
4004092,2021-04-15,S&P Global ESG Score,S&P Global ESG Score,86,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,EMS: Certification/ Audit/ Verification,75,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Emissions Reduction Targets,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Energy Consumption,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Hazardous Waste,90,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Water Consumption,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Anti-Competitive Practices,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Board Gender Diversity,86,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Board Industry Experience,28,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Board Type,76,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,CEO Compensation - Long-Term Performance Alignment,58,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Codes of Conduct: Systems/ Procedures,78,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Compliance to Regulatory Standards,68,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Corruption & Bribery Cases,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Customer Satisfaction Measurement,76,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,ESG Integration in SCM Strategy,60,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Effective Tax Rate,68,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Emerging Risks,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,IT Security/ Cybersecurity Breaches,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,IT Security/ Cybersecurity Governance,50,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,IT Security/ Cybersecurity Measures,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,IT Security/ Cybersecurity Process & Infrastructure,74,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Largest Contributions & Expenditures,60,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Management Ownership Requirements,68,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Material Issues for Enterprise Value Creation,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Materiality Analysis,75,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Non-Executive Chairperson/ Lead Director,70,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Product Innovations (Healthcare),58,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Product Recalls (Health Care),80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,R&D breakout by Innovation Phase,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Reporting on breaches,25,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Risk Governance,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Supplier Risk Management Measures,85,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Supply Chain Risk Exposure,88,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Supply Chain Transparency & Reporting,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Tax Reporting,0,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Tax Strategy and Governance,50,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Access to Healthcare Programs (Products),71,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Corporate Citizenship Strategy,95,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Employee Support Programs,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Employee Turnover Rate,67,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Fatalities,70,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Freedom of Association,50,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Gender Pay Indicators,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Human Capital Return on Investment,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Human Rights Assessment,31,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Human Rights Commitment,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Human Rights Due Diligence Process,80,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Human Rights Mitigation & Remediation,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,91,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,51,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Occupational Illness Frequency Rate (OIFR) - Employees,76,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Return on Employee Development Investment,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Trend of Employee Wellbeing,45,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Question,Workforce Breakdown: Gender,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Dimension,Economic Governance Dimension,84,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Dimension,Environmental Dimension,95,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Dimension,Social Dimension,87,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Climate Strategy,91,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Environmental Policy & Management Systems,86,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Operational Eco-Efficiency,98,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Business Ethics,84,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Corporate Governance,79,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Customer Relationship Management,92,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Information Security/ Cybersecurity & System Availability,77,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Innovation Management,84,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Materiality,93,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Policy Influence,74,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Product Quality & Recall Management,74,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Risk & Crisis Management,98,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Supply Chain Management,89,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Tax Strategy,39,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Access to Healthcare,81,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Corporate Citizenship & Philanthropy,97,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Human Capital Development,96,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Human Rights,78,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Labor Practice Indicators,79,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Occupational Health & Safety,78,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2021-04-15,Criteria,Talent Attraction & Retention,77,001078,ABT,Abbott Laboratories
4004092,2021-11-12,S&P Global ESG Score,S&P Global ESG Score,83,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Climate Risk Assessment - Transition Risks,60,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Climate-Related Scenario Analysis,53,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,EMS: Certification/ Audit/ Verification,74,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Energy Consumption,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Hazardous Waste,35,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Physical Climate Risk Adaptation,30,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,TCFD Disclosure,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Water Consumption,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Anti-Competitive Practices,80,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Board Gender Diversity,86,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Board Industry Experience,28,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Board Type,62,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,CEO Compensation - Long-Term Performance Alignment,58,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Compliance to Regulatory Standards,87,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Corruption & Bribery Cases,80,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Customer Satisfaction Measurement,52,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Effective Tax Rate,33,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Emerging Risks,50,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,IT Security/ Cybersecurity Breaches,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,IT Security/ Cybersecurity Governance,38,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,IT Security/ Cybersecurity Measures,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,IT Security/ Cybersecurity Process & Infrastructure,74,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Largest Contributions & Expenditures,60,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Management Ownership Requirements,76,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Material Issues for Enterprise Value Creation,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Materiality Analysis,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Non-Executive Chairperson/ Lead Director,70,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Process Innovations,50,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Product Innovations (Healthcare),51,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Product Recalls (Health Care),82,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,R&D breakout by Innovation Phase,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Reporting on breaches,50,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Risk Governance,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Supplier Risk Management Measures,74,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Supply Chain Risk Exposure,88,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Supply Chain Transparency & Reporting,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Tax Reporting,0,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Tax Strategy and Governance,32,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Access to Healthcare Programs (Products),71,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Corporate Citizenship Strategy,95,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Discrimination & Harassment,90,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Employee Support Programs,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Employee Turnover Rate,47,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Fatalities,76,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Freedom of Association,0,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Gender Pay Indicators,88,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Hiring,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Human Rights Assessment,18,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Human Rights Commitment,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Human Rights Due Diligence Process,20,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Human Rights Mitigation & Remediation,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,92,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Partnerships for Access to Healthcare,67,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,People Analytics,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Strategic Workforce Planning,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Training & Development Inputs,80,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Trend of Employee Wellbeing,,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Type of Philanthropic Activities,50,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Workforce Breakdown: Gender,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Workforce Breakdown: Other Minorities,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Dimension,Economic Governance Dimension,79,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Dimension,Environmental Dimension,91,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Dimension,Social Dimension,86,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Climate Strategy,87,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Environmental Policy & Management Systems,86,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Operational Eco-Efficiency,90,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Business Ethics,68,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Corporate Governance,77,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Customer Relationship Management,84,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Information Security/ Cybersecurity & System Availability,73,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Innovation Management,72,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Materiality,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Policy Influence,74,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Product Quality & Recall Management,84,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Risk & Crisis Management,71,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Supply Chain Management,93,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Tax Strategy,23,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Access to Healthcare,70,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Corporate Citizenship & Philanthropy,85,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Human Capital Development,94,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Human Rights,60,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Labor Practice Indicators,84,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Occupational Health & Safety,89,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2021-11-12,Criteria,Talent Attraction & Retention,85,001078,ABT,Abbott Laboratories
4004092,2022-04-15,S&P Global ESG Score,S&P Global ESG Score,80,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Climate Risk Assessment - Transition Risks,60,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Climate-Related Scenario Analysis,53,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,EMS: Certification/ Audit/ Verification,74,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Energy Consumption,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Hazardous Waste,35,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Physical Climate Risk Adaptation,30,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,TCFD Disclosure,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Water Consumption,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Anti-Competitive Practices,80,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Board Gender Diversity,86,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Board Industry Experience,28,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Board Type,62,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,CEO Compensation - Long-Term Performance Alignment,58,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Compliance to Regulatory Standards,87,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Corruption & Bribery Cases,80,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Customer Satisfaction Measurement,76,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Effective Tax Rate,26,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Emerging Risks,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,IT Security/ Cybersecurity Breaches,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,IT Security/ Cybersecurity Governance,38,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,IT Security/ Cybersecurity Measures,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,IT Security/ Cybersecurity Process & Infrastructure,74,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Largest Contributions & Expenditures,60,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Management Ownership Requirements,76,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Material Issues for Enterprise Value Creation,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Materiality Analysis,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Non-Executive Chairperson/ Lead Director,70,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Process Innovations,50,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Product Innovations (Healthcare),51,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Product Recalls (Health Care),82,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,R&D breakout by Innovation Phase,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Reporting on breaches,50,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Risk Governance,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Supplier Risk Management Measures,74,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Supply Chain Risk Exposure,88,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Supply Chain Transparency & Reporting,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Tax Reporting,0,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Tax Strategy and Governance,32,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Access to Healthcare Programs (Products),71,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Corporate Citizenship Strategy,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Discrimination & Harassment,90,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Employee Support Programs,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Employee Turnover Rate,52,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Fatalities,76,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Freedom of Association,0,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Gender Pay Indicators,88,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Hiring,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Human Rights Assessment,18,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Human Rights Commitment,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Human Rights Due Diligence Process,50,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Human Rights Mitigation & Remediation,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,92,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Partnerships for Access to Healthcare,67,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,People Analytics,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Strategic Workforce Planning,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Training & Development Inputs,80,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Trend of Employee Wellbeing,,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Type of Philanthropic Activities,50,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Workforce Breakdown: Gender,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Workforce Breakdown: Other Minorities,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Dimension,Economic Governance Dimension,73,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Dimension,Environmental Dimension,91,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Dimension,Social Dimension,86,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Climate Strategy,87,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Environmental Policy & Management Systems,86,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Operational Eco-Efficiency,90,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Business Ethics,68,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Corporate Governance,77,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Customer Relationship Management,92,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Information Security/ Cybersecurity & System Availability,73,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Innovation Management,72,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Materiality,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Policy Influence,74,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Product Quality & Recall Management,59,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Risk & Crisis Management,33,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Supply Chain Management,93,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Tax Strategy,21,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Access to Healthcare,70,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Corporate Citizenship & Philanthropy,88,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Human Capital Development,94,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Human Rights,47,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Labor Practice Indicators,84,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Occupational Health & Safety,89,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Talent Attraction & Retention,86,001078,ABT,Abbott Laboratories
4004092,2022-04-15,S&P Global ESG Score,S&P Global ESG Score,80,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Climate Risk Assessment - Transition Risks,60,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Climate-Related Scenario Analysis,53,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,EMS: Certification/ Audit/ Verification,74,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Energy Consumption,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Hazardous Waste,35,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Physical Climate Risk Adaptation,30,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,TCFD Disclosure,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Water Consumption,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Anti-Competitive Practices,80,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Board Gender Diversity,86,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Board Industry Experience,28,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Board Type,62,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,CEO Compensation - Long-Term Performance Alignment,58,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Compliance to Regulatory Standards,87,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Corruption & Bribery Cases,80,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Customer Satisfaction Measurement,76,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Effective Tax Rate,26,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Emerging Risks,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Emerging Risks,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,IT Security/ Cybersecurity Breaches,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,IT Security/ Cybersecurity Governance,38,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,IT Security/ Cybersecurity Measures,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,IT Security/ Cybersecurity Process & Infrastructure,74,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Largest Contributions & Expenditures,60,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Management Ownership Requirements,76,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Material Issues for Enterprise Value Creation,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Materiality Analysis,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Non-Executive Chairperson/ Lead Director,70,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Process Innovations,50,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Product Innovations (Healthcare),51,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Product Recalls (Health Care),82,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,R&D breakout by Innovation Phase,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Reporting on breaches,50,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Risk Governance,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Risk Governance,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Supplier Risk Management Measures,74,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Supply Chain Risk Exposure,88,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Supply Chain Transparency & Reporting,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Tax Reporting,0,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Tax Strategy and Governance,32,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Access to Healthcare Programs (Products),71,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Corporate Citizenship Strategy,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Discrimination & Harassment,90,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Employee Support Programs,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Employee Turnover Rate,52,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Fatalities,76,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Freedom of Association,0,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Gender Pay Indicators,88,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Hiring,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Human Rights Assessment,18,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Human Rights Commitment,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Human Rights Due Diligence Process,50,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Human Rights Mitigation & Remediation,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,92,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Partnerships for Access to Healthcare,67,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,People Analytics,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Strategic Workforce Planning,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Trend of Employee Wellbeing,,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Type of Philanthropic Activities,50,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Workforce Breakdown: Gender,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Workforce Breakdown: Other Minorities,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Dimension,Economic Governance Dimension,73,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Dimension,Environmental Dimension,91,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Dimension,Social Dimension,86,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Climate Strategy,87,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Environmental Policy & Management Systems,86,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Operational Eco-Efficiency,90,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Business Ethics,68,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Corporate Governance,77,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Customer Relationship Management,92,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Information Security/ Cybersecurity & System Availability,73,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Innovation Management,72,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Materiality,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Policy Influence,74,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Product Quality & Recall Management,59,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Risk & Crisis Management,33,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Risk & Crisis Management,33,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Supply Chain Management,93,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Tax Strategy,21,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Access to Healthcare,70,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Corporate Citizenship & Philanthropy,88,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Human Capital Development,94,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Human Rights,47,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Labor Practice Indicators,84,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Occupational Health & Safety,89,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2022-04-15,Criteria,Talent Attraction & Retention,86,001078,ABT,Abbott Laboratories
4004092,2022-10-21,S&P Global ESG Score,S&P Global ESG Score,79,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Biodiversity Commitment,0,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Climate Risk Assessment - Transition Risks,85,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Climate-Related Scenario Analysis,65,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Direct Greenhouse Gas Emissions (Scope 1),90,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,EMS: Certification/ Audit/ Verification,84,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Energy Consumption,90,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Environmental Policy & Commitments,64,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Financial Risks of Climate Change,20,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Hazardous Waste,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Net-Zero Commitment,0,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,No Deforestation Commitment,0,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Physical Climate Risk Adaptation,30,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,TCFD Disclosure,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Water Consumption,90,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Anti-Competitive Practices,50,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Board Gender Diversity,78,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Board Industry Experience,30,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Board Type,95,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,CEO Compensation - Long-Term Performance Alignment,58,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Compliance to Regulatory Standards,97,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Corruption & Bribery Cases,80,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Effective Tax Rate,67,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Emerging Risks,50,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Emerging Risks,50,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,IT Security/ Cybersecurity Breaches,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,IT Security/ Cybersecurity Governance,75,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,IT Security/ Cybersecurity Measures,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,IT Security/ Cybersecurity Process & Infrastructure,50,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Largest Contributions & Expenditures,60,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Management Ownership Requirements,60,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Material Issues for Enterprise Value Creation,92,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Materiality Analysis,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Product Innovations (Healthcare),58,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Product Recalls (Health Care),83,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,R&D breakout by Innovation Phase,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Reporting on breaches,50,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Risk Governance,80,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Risk Governance,80,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Supplier Risk Management Measures,84,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Supply Chain Risk Exposure,92,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Supply Chain Transparency & Reporting,96,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Tax Reporting,0,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Tax Strategy and Governance,16,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,UN Global Compact Membership,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Access to Healthcare Programs (Products),80,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Corporate Citizenship Strategy,97,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Customer Satisfaction Measurement,76,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Discrimination & Harassment,90,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Employee Support Programs,78,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Employee Turnover Rate,71,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Ethical Marketing Commitment,0,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Fatalities,80,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Freedom of Association,0,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Gender Pay Indicators,90,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Hiring,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Human Rights Assessment,34,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Human Rights Commitment,84,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Human Rights Due Diligence Process,95,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Human Rights Mitigation & Remediation,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,20,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,96,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,OHS Policy,54,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,OHS Programs,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Partnerships for Access to Healthcare,67,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,People Analytics,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Strategic Workforce Planning,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Trend of Employee Wellbeing,,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Workforce Breakdown: Gender,99,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Workforce Breakdown: Other Minorities,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Dimension,Economic Governance Dimension,74,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Dimension,Environmental Dimension,71,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Dimension,Social Dimension,85,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Biodiversity,0,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Climate Strategy,64,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Environmental Policy & Management Systems,84,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Operational Eco-Efficiency,96,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Business Ethics,77,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Corporate Governance,79,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Information Security/ Cybersecurity & System Availability,78,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Innovation Management,84,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Materiality,94,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Policy Influence,74,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Product Quality & Recall Management,63,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Risk & Crisis Management,48,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Risk & Crisis Management,48,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Supply Chain Management,95,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Tax Strategy,22,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Access to Healthcare,75,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Corporate Citizenship & Philanthropy,99,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Customer Relationship Management,92,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Human Capital Development,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Human Rights,55,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Labor Practice Indicators,84,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Marketing Practices,67,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Occupational Health & Safety,77,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2022-10-21,Criteria,Talent Attraction & Retention,88,001078,ABT,Abbott Laboratories
4004092,2023-01-20,S&P Global ESG Score,S&P Global ESG Score,79,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Biodiversity Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Climate Risk Assessment - Transition Risks,85,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Climate-Related Scenario Analysis,65,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Direct Greenhouse Gas Emissions (Scope 1),90,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,EMS: Certification/ Audit/ Verification,84,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Energy Consumption,90,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Environmental Policy & Commitments,64,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Hazardous Waste,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Net-Zero Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,No Deforestation Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Physical Climate Risk Adaptation,30,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,TCFD Disclosure,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Water Consumption,90,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Anti-Competitive Practices,50,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Board Gender Diversity,78,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Board Industry Experience,30,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Board Type,95,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,CEO Compensation - Long-Term Performance Alignment,58,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Compliance to Regulatory Standards,97,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Corruption & Bribery Cases,80,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Effective Tax Rate,67,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Emerging Risks,50,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,IT Security/ Cybersecurity Breaches,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,IT Security/ Cybersecurity Governance,75,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,IT Security/ Cybersecurity Measures,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,IT Security/ Cybersecurity Process & Infrastructure,50,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Largest Contributions & Expenditures,60,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Management Ownership Requirements,60,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Material Issues for Enterprise Value Creation,92,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Materiality Analysis,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Product Innovations (Healthcare),58,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Product Recalls (Health Care),83,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,R&D breakout by Innovation Phase,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Reporting on breaches,50,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Risk Governance,80,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Supplier Risk Management Measures,84,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Supply Chain Risk Exposure,92,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Supply Chain Transparency & Reporting,96,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Tax Reporting,0,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Tax Strategy and Governance,16,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,UN Global Compact Membership,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Access to Healthcare Programs (Products),80,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Corporate Citizenship Strategy,97,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Customer Satisfaction Measurement,76,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Discrimination & Harassment,90,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Employee Support Programs,78,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Employee Turnover Rate,71,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Ethical Marketing Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Fatalities,80,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Freedom of Association,0,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Gender Pay Indicators,90,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Hiring,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Human Rights Assessment,34,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Human Rights Commitment,84,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Human Rights Due Diligence Process,95,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Human Rights Mitigation & Remediation,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,20,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,96,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,OHS Policy,54,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,OHS Programs,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,People Analytics,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Strategic Workforce Planning,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Trend of Employee Wellbeing,,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Workforce Breakdown: Gender,99,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Workforce Breakdown: Other Minorities,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Dimension,Economic Governance Dimension,74,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Dimension,Environmental Dimension,73,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Dimension,Social Dimension,86,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Biodiversity,0,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Climate Strategy,75,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Environmental Policy & Management Systems,84,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Operational Eco-Efficiency,96,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Business Ethics,77,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Corporate Governance,79,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Information Security/ Cybersecurity & System Availability,78,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Innovation Management,84,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Materiality,94,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Policy Influence,74,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Product Quality & Recall Management,63,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Risk & Crisis Management,48,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Supply Chain Management,95,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Tax Strategy,22,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Access to Healthcare,87,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Corporate Citizenship & Philanthropy,99,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Customer Relationship Management,92,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Human Capital Development,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Human Rights,55,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Labor Practice Indicators,84,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Marketing Practices,67,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Occupational Health & Safety,77,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2023-01-20,Criteria,Talent Attraction & Retention,88,001078,ABT,Abbott Laboratories
4004092,2023-02-17,S&P Global ESG Score,S&P Global ESG Score,81,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Biodiversity Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Climate Risk Assessment - Transition Risks,85,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Climate-Related Scenario Analysis,65,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Direct Greenhouse Gas Emissions (Scope 1),90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,EMS: Certification/ Audit/ Verification,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Energy Consumption,90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Environmental Policy & Commitments,64,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Hazardous Waste,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Net-Zero Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,No Deforestation Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Physical Climate Risk Adaptation,30,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,TCFD Disclosure,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Water Consumption,90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Anti-Competitive Practices,50,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Board Gender Diversity,78,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Board Industry Experience,30,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Board Type,95,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,CEO Compensation - Long-Term Performance Alignment,58,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Compliance to Regulatory Standards,97,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Corruption & Bribery Cases,80,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Effective Tax Rate,67,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Emerging Risks,50,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,IT Security/ Cybersecurity Breaches,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,IT Security/ Cybersecurity Governance,75,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,IT Security/ Cybersecurity Measures,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,IT Security/ Cybersecurity Process & Infrastructure,50,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Largest Contributions & Expenditures,60,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Management Ownership Requirements,60,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Material Issues for Enterprise Value Creation,92,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Materiality Analysis,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Product Innovations (Healthcare),58,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Product Recalls (Health Care),83,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,R&D breakout by Innovation Phase,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Reporting on breaches,50,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Risk Governance,80,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Supplier Risk Management Measures,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Supply Chain Risk Exposure,92,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Supply Chain Transparency & Reporting,96,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Tax Reporting,0,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Tax Strategy and Governance,16,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,UN Global Compact Membership,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Access to Healthcare Programs (Products),80,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Corporate Citizenship Strategy,97,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Customer Satisfaction Measurement,76,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Discrimination & Harassment,90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Employee Support Programs,78,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Employee Turnover Rate,71,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Fatalities,80,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Freedom of Association,0,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Gender Pay Indicators,90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Hiring,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Human Rights Assessment,34,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Human Rights Commitment,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Human Rights Due Diligence Process,95,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Human Rights Mitigation & Remediation,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,20,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,96,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,OHS Policy,64,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,OHS Programs,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,People Analytics,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Strategic Workforce Planning,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Trend of Employee Wellbeing,,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Workforce Breakdown: Gender,99,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Workforce Breakdown: Other Minorities,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Dimension,Economic Governance Dimension,74,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Dimension,Environmental Dimension,73,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Dimension,Social Dimension,90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Biodiversity,0,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Climate Strategy,75,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Environmental Policy & Management Systems,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Operational Eco-Efficiency,96,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Business Ethics,77,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Corporate Governance,79,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Information Security/ Cybersecurity & System Availability,78,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Innovation Management,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Materiality,94,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Policy Influence,74,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Product Quality & Recall Management,63,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Risk & Crisis Management,48,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Supply Chain Management,95,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Tax Strategy,22,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Access to Healthcare,87,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Corporate Citizenship & Philanthropy,99,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Customer Relationship Management,92,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Human Capital Development,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Human Rights,55,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Labor Practice Indicators,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Occupational Health & Safety,79,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Talent Attraction & Retention,88,001078,ABT,Abbott Laboratories
4004092,2023-02-17,S&P Global ESG Score,S&P Global ESG Score,81,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Biodiversity Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Climate Risk Assessment - Transition Risks,85,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Climate Risk Management,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Climate-Related Scenario Analysis,65,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Direct Greenhouse Gas Emissions (Scope 1),90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,EMS: Certification/ Audit/ Verification,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Emissions Reduction Targets,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Energy Consumption,90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Environmental Policy & Commitments,64,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Environmental Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Hazardous Waste,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Net-Zero Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,No Deforestation Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Physical Climate Risk Adaptation,30,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,TCFD Disclosure,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Water Consumption,90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Anti-Competitive Practices,50,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Board Average Tenure,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Board Gender Diversity,78,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Board Industry Experience,30,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Board Type,95,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,CEO Compensation - Long-Term Performance Alignment,58,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Codes of Conduct: Coverage,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Compliance to Regulatory Standards,97,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Corruption & Bribery Cases,80,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Critical Supplier Identification,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Dual Class Shares,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,ESG Integration in SCM Strategy,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Effective Tax Rate,67,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Emerging Risks,50,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,IT Security/ Cybersecurity Breaches,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,IT Security/ Cybersecurity Governance,75,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,IT Security/ Cybersecurity Measures,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,IT Security/ Cybersecurity Process & Infrastructure,50,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Largest Contributions & Expenditures,60,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Management Ownership Requirements,60,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Material Issues for Enterprise Value Creation,92,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Materiality Analysis,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Non-Executive Chairperson/ Lead Director,60,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Product Innovations (Healthcare),58,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Product Recalls (Health Care),83,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,R&D breakout by Innovation Phase,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Reporting on breaches,50,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Risk Governance,80,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Sensitivity Analysis & Stress Testing (including Water an,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Supplier Code of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Supplier Risk Management Measures,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Supply Chain Risk Exposure,92,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Supply Chain Transparency & Reporting,96,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Tax Reporting,0,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Tax Strategy and Governance,16,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,UN Global Compact Membership,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Access to Healthcare Programs (Products),80,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Corporate Citizenship Strategy,97,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Customer Satisfaction Measurement,76,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Discrimination & Harassment,90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Employee Development Programs,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Employee Support Programs,78,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Employee Turnover Rate,71,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Fatalities,80,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Freedom of Association,0,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Gender Pay Indicators,90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Hiring,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Human Rights Assessment,34,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Human Rights Commitment,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Human Rights Due Diligence Process,95,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Human Rights Mitigation & Remediation,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,20,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,96,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,OHS Policy,64,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,OHS Programs,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,People Analytics,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Philanthropic Contributions,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Social Reporting - Assurance,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Social Reporting - Coverage,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Strategic Workforce Planning,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Training & Development Inputs,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Trend of Employee Wellbeing,,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Type of Performance Appraisal,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Type of Philanthropic Activities,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Workforce Breakdown: Gender,99,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Workforce Breakdown: Other Minorities,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Dimension,Economic Governance Dimension,74,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Dimension,Environmental Dimension,73,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Dimension,Social Dimension,90,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Biodiversity,0,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Climate Strategy,75,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Environmental Policy & Management Systems,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Environmental Reporting,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Operational Eco-Efficiency,96,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Business Ethics,77,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Corporate Governance,79,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Information Security/ Cybersecurity & System Availability,78,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Innovation Management,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Materiality,94,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Policy Influence,74,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Product Quality & Recall Management,63,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Risk & Crisis Management,48,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Supply Chain Management,95,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Tax Strategy,22,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Access to Healthcare,87,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Corporate Citizenship & Philanthropy,99,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Customer Relationship Management,92,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Human Capital Development,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Human Rights,55,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Labor Practice Indicators,84,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Occupational Health & Safety,79,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Social Reporting,100,001078,ABT,Abbott Laboratories
4004092,2023-02-17,Criteria,Talent Attraction & Retention,88,001078,ABT,Abbott Laboratories
4004092,2023-10-27,S&P Global ESG Score,S&P Global ESG Score,74,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Biodiversity Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Biodiversity Risk Assessment,4,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Climate Governance,75,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Climate Risk Management,91,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Climate-Related Scenario Analysis,65,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,EMS: Certification/ Audit/ Verification,68,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Emissions Reduction Targets,70,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,End of Life Cycle Responsibility,38,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Energy Consumption,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Environmental Policy & Commitments,74,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Exposure to Hazardous Substances,40,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Hazardous Waste,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Life Cycle Assessment,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Net-Zero Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,No Deforestation Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Physical Climate Risk Adaptation,50,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Product Design Criteria,60,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Resource Efficiency Benefits of Products,50,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,TCFD Disclosure,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Water Consumption,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Average Tenure,77,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Gender Diversity,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Independence,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Industry Experience,30,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Type,94,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,CEO Compensation - Long-Term Performance Alignment,58,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Compliance to Regulatory Standards,40,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Effective Tax Rate,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Emerging Risks,30,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,IT Security/ Cybersecurity Governance,88,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,IT Security/ Cybersecurity Measures,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,IT Security/ Cybersecurity Process & Infrastructure,55,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,KPIs for Supplier Assessment and Development,17,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,KPIs for Supplier Screening,80,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Largest Contributions & Expenditures,60,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Lobbying and Trade Associations - Climate Alignment,13,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Management Ownership Requirements,60,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Material Issues for Enterprise Value Creation,83,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Material Issues for External Stakeholders,93,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Materiality Analysis,35,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Materiality Metrics for Enterprise Value Creation,80,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Materiality Metrics for External Stakeholders,60,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Non-Executive Chairperson/ Lead Director,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Product Innovations (Healthcare),58,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Product Recalls (Health Care),83,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,R&D breakout by Innovation Phase,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Reporting on breaches,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Risk Governance,60,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Risk Management Processes,45,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Supplier Assessment and Development,70,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Supplier Code of Conduct,75,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Supplier ESG Program,25,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Supplier Screening,74,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Sustainability Reporting Boundaries,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Sustainability Taxonomies,,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Tax Reporting,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Tax Strategy and Governance,16,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,UN Global Compact Membership,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Access to Healthcare Programs (Products),100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Customer Satisfaction Measurement,92,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Discrimination & Harassment,90,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Employee Development Programs,48,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Employee Support Programs,81,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Employee Turnover Rate,67,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Fatalities,80,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Freedom of Association,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Gender Pay Indicators,90,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Hiring,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Human Rights Assessment,18,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Human Rights Commitment,84,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Human Rights Due Diligence Process,95,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Human Rights Mitigation & Remediation,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,20,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,OHS Policy,76,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,OHS Programs,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Training & Development Inputs,80,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Trend of Employee Wellbeing,25,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Type of Performance Appraisal,87,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Workforce Breakdown: Gender,99,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Dimension,Economic Governance Dimension,67,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Dimension,Environmental Dimension,65,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Dimension,Social Dimension,85,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Biodiversity,1,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Climate Strategy,66,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Environmental Policy & Management Systems,80,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Product Stewardship,29,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Business Ethics,70,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Corporate Governance,76,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Information Security/ Cybersecurity & System Availability,82,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Innovation Management,84,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Materiality,71,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Policy Influence,65,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Product Quality & Recall Management,49,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Risk & Crisis Management,51,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Supply Chain Management,53,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Tax Strategy,29,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Customer Relationship Management,97,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Human Capital Development,75,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Human Rights,59,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Labor Practice Indicators,80,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Occupational Health & Safety,79,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Talent Attraction & Retention,72,001078,ABT,Abbott Laboratories
4004092,2023-10-27,S&P Global ESG Score,S&P Global ESG Score,74,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Biodiversity Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Biodiversity Risk Assessment,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Climate Governance,75,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Climate Risk Management,91,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Climate-Related Management Incentives,90,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Climate-Related Scenario Analysis,65,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Coverage of Environmental Management Policy,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Direct Greenhouse Gas Emissions (Scope 1),100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,EMS: Certification/ Audit/ Verification,68,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Emissions Reduction Targets,70,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,End of Life Cycle Responsibility,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Energy Consumption,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Environmental Policy & Commitments,74,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Exposure to Hazardous Substances,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Financial Opportunities Arising from Climate Change,,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Financial Risks of Climate Change,,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Hazardous Waste,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Life Cycle Assessment,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Net-Zero Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,No Deforestation Commitment,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Physical Climate Risk Adaptation,50,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Product Design Criteria,60,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Resource Efficiency Benefits of Products,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,TCFD Disclosure,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Waste Disposal,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Water Consumption,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Average Tenure,77,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Diversity Policy,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Effectiveness,68,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Gender Diversity,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Independence,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Industry Experience,30,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Board Type,94,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,CEO Compensation - Long-Term Performance Alignment,58,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,CEO Compensation - Success Metrics,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,CEO-to-Employee Pay Ratio,30,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Codes of Conduct,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Codes of Conduct: Systems/ Procedures,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Compliance to Regulatory Standards,40,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Contributions & Other Spending,83,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Corruption & Bribery,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Effective Tax Rate,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Emerging Risks,30,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Family Ownership,,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Government Ownership,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,IT Security/ Cybersecurity Governance,88,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,IT Security/ Cybersecurity Measures,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,IT Security/ Cybersecurity Process & Infrastructure,55,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,KPIs for Supplier Assessment and Development,17,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,KPIs for Supplier Screening,80,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Largest Contributions & Expenditures,60,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Lobbying and Trade Associations - Climate Alignment,13,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Management Ownership,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Management Ownership Requirements,60,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Material Issues for Enterprise Value Creation,83,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Material Issues for External Stakeholders,93,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Materiality Analysis,35,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Materiality Metrics for Enterprise Value Creation,80,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Materiality Metrics for External Stakeholders,60,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Non-Executive Chairperson/ Lead Director,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Open Innovation,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Process Innovations,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Product Innovations (Healthcare),58,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Product Recalls (Health Care),83,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,R&D Spending,,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,R&D breakout by Innovation Phase,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Reporting on breaches,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Risk Culture,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Risk Governance,60,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Risk Management Processes,45,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Supplier Assessment and Development,70,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Supplier Code of Conduct,75,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Supplier ESG Program,25,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Supplier Screening,74,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Sustainability Reporting Assurance,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Sustainability Reporting Boundaries,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Sustainability Taxonomies,,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Tax Reporting,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Tax Strategy and Governance,16,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,UN Global Compact Membership,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Access to Healthcare Programs (Products),100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Accessibility & Transparency of Outcome Data,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Customer Satisfaction Measurement,92,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Direct-to-Consumer Marketing,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Discrimination & Harassment,90,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Employee Development Programs,48,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Employee Support Programs,81,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Employee Turnover Rate,67,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Ethical Marketing - Complaints Tracking,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Ethical Marketing Commitment,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Fatalities,80,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Freedom of Association,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Gender Pay Indicators,90,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Hiring,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Human Capital Return on Investment,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Human Rights Assessment,18,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Human Rights Commitment,84,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Human Rights Due Diligence Process,95,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Human Rights Mitigation & Remediation,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Long-Term Incentives for Employees,95,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,20,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Measure Contribution to Health Outcome,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,OHS Policy,76,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,OHS Programs,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Partnerships for Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Sales Channels Variety & Innovation,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Sales Effectiveness Targets,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Training & Development Inputs,80,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Trend of Employee Wellbeing,25,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Type of Performance Appraisal,87,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Workforce Breakdown: Gender,99,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Dimension,Economic Governance Dimension,67,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Dimension,Environmental Dimension,63,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Dimension,Social Dimension,85,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Biodiversity,0,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Climate Strategy,66,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Environmental Policy & Management Systems,80,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Product Stewardship,12,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Business Ethics,70,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Corporate Governance,76,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Information Security/ Cybersecurity & System Availability,82,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Innovation Management,84,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Materiality,71,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Policy Influence,65,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Product Quality & Recall Management,49,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Risk & Crisis Management,51,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Supply Chain Management,53,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Tax Strategy,29,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Access to Healthcare,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Customer Relationship Management,97,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Health Outcome Contribution,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Human Capital Development,75,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Human Rights,59,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Labor Practice Indicators,80,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Marketing Practices,100,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Occupational Health & Safety,79,001078,ABT,Abbott Laboratories
4004092,2023-10-27,Criteria,Talent Attraction & Retention,72,001078,ABT,Abbott Laboratories
